MRNA: Moderna Inc Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 66,957.71
Enterprise Value ($M) 64,084.71
Book Value ($M) 17,985.00
Book Value / Share 45.97
Price / Book 3.72
NCAV ($M) 5,505.00
NCAV / Share 14.07
Price / NCAV 12.16

Profitability (mra)
Return on Invested Capital (ROIC) 0.74
Return on Assets (ROA) 0.87
Return on Equity (ROE) 2.10

Liquidity (mrq)
Quick Ratio 1.71
Current Ratio 1.99

Balance Sheet (mrq) ($M)
Current Assets 13,563.00
Assets 26,043.00
Liabilities 8,058.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Bancel Stephane 7.64 10.04
02-14 13G/A Flagship Ventures Fund IV General Partner LLC 4.90 -39.63
02-10 13G/A Vanguard Group Inc 6.76 17.35
02-04 13G BlackRock Inc. 6.80 42.65
01-26 13G/A Baillie Gifford & Co 11.29 2.42

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2022-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2022-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2022-02-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-08-12 575,441 2,514,227 22.89
2022-08-11 721,103 3,004,521 24.00
2022-08-10 623,127 3,088,712 20.17
2022-08-09 954,148 4,722,575 20.20
2022-08-08 887,646 3,779,935 23.48

(click for more detail)

(click for list of largest short owners)

Similar Companies
MORF – Morphic Holding Inc MREO – Mereo BioPharma Group plc
MRKR – Marker Therapeutics Inc MRNS – Marinus Pharmaceuticals Inc
MRSN – Mersana Therapeutics Inc


Financial data and stock pages provided by
Fintel.io